A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families

American Journal of Human Genetics

Volumn 60, Issue 5, 1997, Pages 1041-1049

  Peelen, T ^a   Van Vliet, M ^a   Petrij Bosch, A ^a   Mieremet, R ^a   Szabo, C ^c   Van Den Ouweland, A M W ^d   Hogervorst, F ^e   Brohet, R ^e   Ligtenberg, M J L ^g   Teugels, E ^h   Van Der Luijt, R ⁱ   Van Der Hout, A H ^j   Gille, J J P ^f   Pals, G ^f   Jedema, I ^a   Olmer, R ^a   Van Leeuwen, I ^a,b   Newman, B ^k   Plandsoen, M ^d   Van Der Est, M ^d   Brink, G ^e   Hageman, S ^e   Arts, P J W ^g   Bakker, M M ^g   Willems, H W ^g   Van Der Looij, E ^g   Neyns, B ^h   Bonduelle, M ^h   Jansen, R ⁱ   Oosterwijk, J C ^a,j   Sijmons, R ^j   Smeets, H J M ^l   Van Asperen, C J ^a   Meijers Heijboer, H ^d   Klijn, J G M ^d   De Greve, J ^h   King, M C ^c   Menko, F H ^f   Brunner, H G ^g   Halley, D ^d   Van Ommen, G J B ^a   Vasen, H F A ^b   Cornelisse, C J ^a   Van 't Veer, L J ^e   De Knijff, P ^a   Bakker, E ^a   Devilee, P ^a,m   more..

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Found Detection of Hered Tumors   (Netherlands)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f VU UNIVERSITY AMSTERDAM   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h FREE UNIVERSITY OF BRUSSELS   (Belgium)

ⁱ UTRECHT UNIVERSITY   (Netherlands)

^j UNIVERSITY OF GRONINGEN   (Netherlands)

^k UNIVERSITY OF NORTH CAROLINA   (United States)

^l Department of Clinical Genetics ^*  (Netherlands)

^m LEIDEN UNIVERSITY   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BREAST CANCER; CANCER FAMILY; CANCER INCIDENCE; FAMILIAL CANCER; FEMALE; GENE MUTATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; OVARY CANCER; PRIORITY JOURNAL;

ADULT; BELGIUM; BREAST NEOPLASMS; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENES, BRCA1; GENETIC SCREENING; GENOTYPE; HAPLOTYPES; HUMANS; INCIDENCE; MUTATION; NETHERLANDS; OVARIAN NEOPLASMS; PHENOTYPE;

EID: 16944365091     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Anderson L, Friedman L, Osborne-Lawrence S, Lynch E, Weissenbach J, Bowcock A, King M (1993) High-density genetic map of the BRCA1 region of chromosome 17q12-q21. Genomics 17:618-623
2. Andersen TI, Børresen A-L, Moller P (1996) A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am J Hum Genet 59:486-487
3. Berman DB, Wagner-Costalas J, Schultz DC, Lynch HT, Daly M, Godwin AK (1996) Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 58:1166-1176
4. Beutler E, McKusick VA, Motulsky AG, Scriver CR, Hutchinson F (1996) Mutation nomenclature: nicknames, systematic names, and unique identifiers. Hum Mutat 8:203-206
5. Breast Cancer Information Core (1996) http://www.nhgri.nih .gov/Intramural_research/Lab_transfer/Bic
6. Caligo MA, Ghimenti C, Cipollini G, Ricci S, Brunetti I, Marchetti V, Olsen R, et al (1996) BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations. Oncogene 13:1483-1488
7. Castilla L, Couch F, Erdos M, Hoskins K, Calzone K, Garber J, Boyd J, et al (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 8:387-391
8. Cornells R, Vasen H, Meijers-Heijboer H, Ford D, Van Vliet M, Van Tilborg A, Cleton F, et al (1995) Age at diagnosis as an indicator of eligibility for BRCA1 DNA-testing in familial breast cancer. Hum Genet 95:539-544
9. Couch FJ, Weber BL, Borresen AL, Brody L, Casey G, Devilee P, Fitzgerald M, et al (1996) Mutations and polymorphisms in the familial early onset breast cancer (BRCA1) gene. Hum Mutat 8:8-18
10. Easton DF, Bishop DT, Ford D, Crockford GP, Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52:678-701
11. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271
12. Ford D, Easton D (1995) The genetics of breast and ovarian cancer. Br J Cancer 72:805-812
13. Ford D, Easton D, Bishop D, Narod S, Goldgar D, Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695
14. Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457-1462
15. Friedman L, Ostermeyer E, Szabo C, Dowd P, Lynch E, Rowell S, King M (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399-404
16. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, et al (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57:1284-1297
17. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, et al (1995) Germline mutations of the BRCA 1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428-433
18. Hall J, Lee M, Newman B, Morrow J, Anderson L, Huey B, King M (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684-1689
19. Hogervorst F, Cornells R, Bout M, Van Vliet M, Oosterwjjk J, Olmer R, Bakker B, et al (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 10:208-212
20. Johannsson O, Ostermeyer EA, Håkansson S, Friedman LS, Johansson U, Sellberg G, Brondum-Nielsen K, et al (1996) Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet 58:441-450
21. Miki Y, Swensen J, Shattuck-Eidens D, Futreal P, Harshman K, Tavtigian S, Liu Q, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
22. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
23. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, et al (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58: 271-280
24. Peelen T, Cornells RC, Van Vliet M, Petrij-Bosch A, Cleton-Jansen A-M, Meijers-Heijboer H, Klijn JGM, et al (1996) The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2. Eur J Hum Genet 4: 225-230
25. Risch N, De Leon D, Ozelius L, Kramer P, Almasy L, Singer B, Fahn S, et al (1995) Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet 9:152-159
26. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187
27. Saiki RK, Bugavvan TL, Horn GT, Mullis KB, Ehrlich HA (1986) Analysis of enzymatically amplified β-globin and HLA-DQa DNA with allele-specific oligonucleotide probes. Nature 324:163-166
28. Serova O, Montagna M, Torchard D, Narod SA, Tonin P, Sylla B, Lynch HT, et al (1996) A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 58:42-51
29. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, et al (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 273:535-541
30. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, et al (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392-398
31. Struewing J, Abeliovich D, Peretz T, Avishai N, Kaback M, Collins F, Brody L (1995a) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200
32. Struewing JP, Brody LC, Erdos MR, Kase RG, Giambarresi TR, Smith SA, Collins FS, et al (1995k) Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 57:1-7
33. Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, et al (1995) BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 57:189
34. Van der Luijt R, Meera Khan P, Vasen H, Van Leeuwen C, Tops C, Roest P, Den Dunnen J, et al (1994) Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics 20:1-4
35. Wagner TMU, Moslinger R, Zielinski C, Scheiner O, Breiteneder H (1996) New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families. Lancet 347: 1263
36. Weber J, Wong C (1993) Mutation of human short tandem repeats. Hum Mol Genet 2:1123-1128